Certified by Founder Lodge
Gero
United States - Palo Alto, California
START UP
1 Disclosed Funding Rounds $6,000,000
0 Participating Investments
-
Founded date
2018
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases
We use AI to build clinically relevant disease phenotypes in real-world human data and
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 20 ,2023 | Series A | $6,000,000 |
VitaDAO
Melnichek Investments LTD
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Naoma AI | $440,000 | (Feb 4, 2026)
Derapi | $7,000,000 | (Feb 4, 2026)
Arbor(US) | $6,300,000 | (Feb 4, 2026)
Graici | $7,500,000 | (Feb 4, 2026)
enclaive | $4,849,418 | (Feb 4, 2026)
